- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 9.89M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 10.07M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 9.55M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $77.83K |
| Capex | Q1 2026 · Mar 31, 2025 | $27.63K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$922.49K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.23M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $10.93M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $9.82M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $11.75M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $11.53M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $12.97M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $13.58M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $70.03M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $63.92M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $74.23M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $68.28M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $72.88M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $66.21M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $85.98M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $79.81M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.83M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $4.73M |
| Net Income | Q1 2026 · Mar 31, 2026 | $76.96K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$724.06K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$58.37K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$816.43K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $5.6M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $4.78M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $34.98M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $28.73M |
| Revenue | Q1 2026 · Mar 31, 2026 | $40.58M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $33.51M |